Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation

J Biol Chem. 2016 Dec 16;291(51):26586. doi: 10.1074/jbc.A116.717736.
No abstract available

Publication types

  • Published Erratum